Literature DB >> 17644288

Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.

Kumar A Shah1, Abhijit A Date, Medha D Joshi, Vandana B Patravale.   

Abstract

The objective of this investigation was to develop solid lipid nanoparticles (SLN) of tretinoin (TRE) with the help of facile and simple emulsification-solvent diffusion (ESD) technique and to evaluate the viability of an SLN based gel in improving topical delivery of TRE. The feasibility of fabricating SLN of TRE by the ESD method was successfully demonstrated in this investigation. The developed SLN were characterized for particle size, polydispersity index, entrapment efficiency of TRE and morphology. Studies were carried out to evaluate the ability of SLN in improving the photostability of TRE as compared to TRE in methanol. Encapsulation of TRE in SLN resulted in a significant improvement in its photostability in comparison to methanolic TRE solution and also prevented its isomerization. Furthermore, the skin irritation studies carried out on rabbits showed that SLN based TRE gel is significantly less irritating to skin as compared to marketed TRE cream and clearly indicated its potential in improving the skin tolerability of TRE. In vitro permeation studies through rat skin indicated that an SLN based TRE gel has permeation profile comparable to that of the marketed TRE cream.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644288     DOI: 10.1016/j.ijpharm.2007.05.061

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  34 in total

1.  Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.

Authors:  Navjot Kaur; Richa Puri; Subheet Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

Review 2.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

3.  Formulation and evaluation of Adapalene-loaded nanoparticulates for epidermal localization.

Authors:  Mangesh Bhalekar; Prashant Upadhaya; Ashwini Madgulkar
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

4.  Enhanced dermal delivery of acyclovir using solid lipid nanoparticles.

Authors:  Sanyog Jain; Meghal A Mistry; Nitin K Swarnakar
Journal:  Drug Deliv Transl Res       Date:  2011-10       Impact factor: 4.617

5.  Polymer conjugated retinoids for controlled transdermal delivery.

Authors:  Steven A Castleberry; Mohiuddin A Quadir; Malak Abu Sharkh; Kevin E Shopsowitz; Paula T Hammond
Journal:  J Control Release       Date:  2017-07-06       Impact factor: 9.776

6.  Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical Trial.

Authors:  B S Chandrashekhar; M Anitha; Mukesh Ruparelia; Pradyumna Vaidya; Riyaz Aamir; Sunil Shah; S Thilak; Sanjeev Aurangabadkar; Sandeep Pal; Abir Saraswat; Jayesh J Sanmukhani
Journal:  J Clin Diagn Res       Date:  2015-01-01

7.  Acid-responsive polymeric nanocarriers for topical adapalene delivery.

Authors:  Chenchen Guo; Rajeshree H Khengar; Mingjing Sun; Zheng Wang; Aiping Fan; Yanjun Zhao
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

8.  Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials.

Authors:  P Severino; J F Fangueiro; S V Ferreira; R Basso; M V Chaud; M H A Santana; A Rosmaninho; E B Souto
Journal:  Clin Transl Oncol       Date:  2013-01-24       Impact factor: 3.405

9.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

10.  Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.

Authors:  Pankaj Pathak; Mangal Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2009-07-30       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.